Compare Navan Inc. Class A Common Stock (NAVN) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Navan Inc. Class A Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Navan Inc. Class A Common Stock trades at $23.63 (market cap $6.01B), while Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B). The key difference: Navan Inc. Class A Common Stock is far larger — about 3.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Navan Inc. Class A Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Navan Inc. Class A Common Stock for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| NAVN | NUVB | |
|---|---|---|
Market Cap | $6.01B | $1.74B |
Volume | 2,990,425 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $30.58 | $9.54 |
52-Week Low | $8.51 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.36B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Navan Inc. Class A Common Stock
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
